{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:33:50Z","timestamp":1776713630032,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,8,23]],"date-time":"2015-08-23T00:00:00Z","timestamp":1440288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00774-015-0706-y","type":"journal-article","created":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T09:27:06Z","timestamp":1440235626000},"page":"587-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate"],"prefix":"10.1007","volume":"34","author":[{"given":"Emilio","family":"Gonz\u00e1lez-Parra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Ace\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Tar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Gonz\u00e1lez-Casaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Crist\u00f3bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Huelmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mah\u00edllo-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Pello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Carda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Hern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodr\u00edguez-Artalejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"L\u00f3pez-Besc\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,23]]},"reference":[{"key":"706_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"706_CR2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.ajkd.2010.11.007","volume":"57","author":"LA Stevens","year":"2011","unstructured":"Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell AT, Bakris GL, McCullough PA (2011) Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the kidney early evaluation program (KEEP). Am J Kidney Dis 57:S9\u2013S16","journal-title":"Am J Kidney Dis"},{"key":"706_CR3","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.ijcard.2012.11.014","volume":"167","author":"E Abu-Assi","year":"2013","unstructured":"Abu-Assi E, Lear P, Cabanas-Grand\u00edo P, Rodr\u00edguez-Girondo M, Raposeiras-Roubin S, Pereira-L\u00f3pez E, Roman\u00ed SG, Gil CP, Garc\u00eda-Acu\u00f1a JM, Gonz\u00e1lez-Juanatey JR (2013) A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all-cause mortality in acute coronary syndrome patients. Int J Cardiol 167:2325\u20132326","journal-title":"Int J Cardiol"},{"key":"706_CR4","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1\u2013S266","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 113","key":"706_CR5","first-page":"1","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76 (Suppl 113):1\u2013130","journal-title":"Kidney Int"},{"key":"706_CR6","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408","journal-title":"J Clin Invest"},{"key":"706_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351","journal-title":"Nature"},{"key":"706_CR8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Qui\u00f1ones H, Griffith C, Kuro-o M, Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124\u2013136","journal-title":"J Am Soc Nephrol"},{"key":"706_CR9","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","volume":"25","author":"K Lindberg","year":"2014","unstructured":"Lindberg K, Amin R, Moe OW, Hu MC, Erben RG, \u00d6stman Wernerson A, Lanske B, Olauson H, Larsson TE (2014) The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol 25:2169\u20132175","journal-title":"J Am Soc Nephrol"},{"key":"706_CR10","doi-asserted-by":"crossref","first-page":"e95402","DOI":"10.1371\/journal.pone.0095402","volume":"9","author":"J Tu\u00f1\u00f3n","year":"2014","unstructured":"Tu\u00f1\u00f3n J, Crist\u00f3bal C, Tar\u00edn N, Ace\u00f1a \u00c1, Gonz\u00e1lez-Casaus ML, Huelmos A, Alonso J, Lorenzo \u00d3, Gonz\u00e1lez-Parra E, Mah\u00edllo-Fern\u00e1ndez I, Pello AM, Carda R, Farr\u00e9 J, Rodr\u00edguez-Artalejo F, L\u00f3pez-Besc\u00f3s L, Egido J (2014) Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease. PLoS One 9:e95402","journal-title":"PLoS One"},{"key":"706_CR11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"706_CR12","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/ndt\/gfq313","volume":"25","author":"J Rojas-Rivera","year":"2010","unstructured":"Rojas-Rivera J, De La Piedra C, Ramos A, Ortiz A, Egido J (2010) The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant 25:2850\u20132865","journal-title":"Nephrol Dial Transplant"},{"key":"706_CR13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2011.09.002","volume":"220","author":"TJ Ellam","year":"2012","unstructured":"Ellam TJ, Chico TJ (2012) Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220:310\u2013318","journal-title":"Atherosclerosis"},{"key":"706_CR14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.carpath.2012.02.008","volume":"21","author":"E Gonzalez-Parra","year":"2012","unstructured":"Gonzalez-Parra E, Tu\u00f1\u00f3n J, Egido J, Ortiz A (2012) Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol 21:372\u2013381","journal-title":"Cardiovasc Pathol"},{"key":"706_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.543","volume":"74","author":"AM Ramos","year":"2008","unstructured":"Ramos AM, Albalate M, V\u00e1zquez S, Caramelo C, Egido J, Ortiz A (2008) Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. Kidney Int Suppl 74:88\u201393","journal-title":"Kidney Int Suppl"},{"key":"706_CR16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","volume":"7","author":"MC Chapuy","year":"1997","unstructured":"Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439\u2013443","journal-title":"Osteoporos Int"},{"key":"706_CR17","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2008","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, K\u00f6nig P, Kraatz G, Mann JF, M\u00fcller GA, K\u00f6hler H, Riegler P (2008) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18:2600\u20132608","journal-title":"J Am Soc Nephrol"},{"key":"706_CR18","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","volume":"27","author":"MC Hu","year":"2012","unstructured":"Hu MC, Kuro-o M, Moe OW (2012) The emerging role of klotho in clinical nephrology. Nephrol Dial Transplant 27:2650\u20132657","journal-title":"Nephrol Dial Transplant"},{"key":"706_CR19","first-page":"275","volume":"32","author":"M Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez M, L\u00f3pez I, Mu\u00f1oz J, Aguilera-Tejero E, Almaden Y (2012) FGF23 and mineral metabolism, implications in CKD-MBD. Nefrologia 32:275\u2013278","journal-title":"Nefrologia"},{"key":"706_CR20","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/gfp784","volume":"25","author":"TE Larsson","year":"2010","unstructured":"Larsson TE (2010) The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe? Nephrol Dial Transplant 25:1376\u20131381","journal-title":"Nephrol Dial Transplant"},{"key":"706_CR21","doi-asserted-by":"publisher","unstructured":"Olmos JM, Hern\u00e1ndez JL, Garc\u00eda-Velasco P, Mart\u00ednez J, Llorca J, Gonz\u00e1lez-Mac\u00edas J (2015) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int. doi: 10.1007\/s00198-015-3219-6","DOI":"10.1007\/s00198-015-3219-6"},{"key":"706_CR22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study. Ann Intern Med 152:640\u2013648","journal-title":"Ann Intern Med"},{"key":"706_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/gfn620","volume":"24","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS (2009) Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant 24:4\u20137","journal-title":"Nephrol Dial Transplant"},{"key":"706_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","volume":"83","author":"J \u00c4rnl\u00f6v","year":"2013","unstructured":"\u00c4rnl\u00f6v J, Carlsson AC, Sundstr\u00f6m J, Ingelsson E, Larsson A, Lind L, Larsson TE (2013) Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int 83:160\u2013166","journal-title":"Kidney Int"},{"key":"706_CR25","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.0000000000000410","volume":"82","author":"CB Wright","year":"2014","unstructured":"Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, Sacco RL, Mendez A, Wolf M (2014) Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology 82:1700\u20131706","journal-title":"Neurology"},{"key":"706_CR26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","volume":"85","author":"R Jimbo","year":"2014","unstructured":"Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T (2014) Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int 85:1103\u20131111","journal-title":"Kidney Int"},{"key":"706_CR27","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2215\/CJN.02560310","volume":"5","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A (2010) Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 5:1780\u20131786","journal-title":"Clin J Am Soc Nephrol"},{"key":"706_CR28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","volume":"162","author":"JL Anderson","year":"2011","unstructured":"Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lapp\u00e9 DL, Muhlestein JB (2011) Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 162:331\u2013339","journal-title":"Am Heart J"},{"key":"706_CR29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/hrt.2011.223529","volume":"97","author":"NC Grandi","year":"2011","unstructured":"Grandi NC, Breitling LP, Hahmann H, W\u00fcsten B, M\u00e4rz W, Rothenbacher D, Brenner H (2011) Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart 97:1215\u20131221","journal-title":"Heart"},{"key":"706_CR30","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstr\u00f6m","year":"2009","unstructured":"Hagstr\u00f6m E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstr\u00f6m J, Melhus H, Held C, Lind L, Micha\u00eblsson K, Arnl\u00f6v J (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765\u20132771","journal-title":"Circulation"},{"key":"706_CR31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","volume":"161","author":"EN Taylor","year":"2011","unstructured":"Taylor EN, Rimm EB, Stampfer MJ, Curhan GC (2011) Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161:956\u2013962","journal-title":"Am Heart J"},{"key":"706_CR32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119\u20131127","journal-title":"JAMA"},{"key":"706_CR33","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","volume":"25","author":"CM Gibson","year":"2004","unstructured":"Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E (2004) Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J 25:1998\u20132005","journal-title":"Eur Heart J"},{"key":"706_CR34","doi-asserted-by":"publisher","first-page":"e102335","DOI":"10.1371\/journal.pone.0102335","volume":"9","author":"PR Kalra","year":"2014","unstructured":"Kalra PR, Garc\u00eda-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG, Investigators CLARIFY (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS One 9:e102335. doi: 10.1371\/journal.pone.0102335","journal-title":"PLoS One"},{"key":"706_CR35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","volume":"75","author":"CM Giachelli","year":"2009","unstructured":"Giachelli CM (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75:890\u2013897","journal-title":"Kidney Int"},{"key":"706_CR36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","volume":"79","author":"AS Dusso","year":"2011","unstructured":"Dusso AS, Tokumoto M (2011) Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int 79:715\u2013729","journal-title":"Kidney Int"},{"key":"706_CR37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78:975\u2013980","journal-title":"Kidney Int"},{"key":"706_CR38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","volume":"23","author":"ME Rodriguez-Ortiz","year":"2012","unstructured":"Rodriguez-Ortiz ME, Lopez I, Mu\u00f1oz-Casta\u00f1eda JR, Martinez-Moreno JM, Ram\u00edrez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190\u20131197","journal-title":"J Am Soc Nephrol"},{"key":"706_CR39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/ajcn\/86.4.959","volume":"86","author":"MJ Bolland","year":"2007","unstructured":"Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, Reid IR (2007) The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr 86:959\u2013964","journal-title":"Am J Clin Nutr"},{"key":"706_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2011.06.046","volume":"218","author":"A Imai","year":"2011","unstructured":"Imai A, Komatsu S, Ohara T, Kamata T, Yoshida J, Miyaji K, Shimizu Y, Takewa M, Hirayama A, Deshpande GA, Takahashi O, Kodama K (2011) Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography. Atherosclerosis 218:350\u2013355","journal-title":"Atherosclerosis"},{"key":"706_CR41","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","volume":"383","author":"A Ortiz","year":"2014","unstructured":"Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM (2014) Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383:1831\u20131843","journal-title":"Lancet"},{"key":"706_CR42","first-page":"43","volume":"44","author":"M Rasouli","year":"2006","unstructured":"Rasouli M, Kiasari AM (2006) Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Clin Chem Lab Med 44:43\u201350","journal-title":"Clin Chem Lab Med"},{"key":"706_CR43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2007.11.004","volume":"199","author":"SJ Onufrak","year":"2008","unstructured":"Onufrak SJ, Bellasi A, Shaw LJ, Herzog CA, Cardarelli F, Wilson PW, Vaccarino V, Raggi P (2008) Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 199:424\u2013431","journal-title":"Atherosclerosis"},{"key":"706_CR44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.ajkd.2010.03.030","volume":"56","author":"G Saab","year":"2010","unstructured":"Saab G, Whooley MA, Schiller NB, Ix JH (2010) Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the heart and soul study. Am J Kidney Dis 56:496\u2013505","journal-title":"Am J Kidney Dis"},{"key":"706_CR45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159\u20131165","journal-title":"Arch Intern Med"},{"key":"706_CR46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ahj.2010.03.031","volume":"159","author":"NC Grandi","year":"2010","unstructured":"Grandi NC, Breitling LP, Vossen CY, Hahmann H, W\u00fcsten B, M\u00e4rz W, Rothenbacher D, Brenner H (2010) Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 159:1044\u20131051","journal-title":"Am Heart J"},{"issue":"Suppl","key":"706_CR47","first-page":"17","volume":"27","author":"E Gonzalez-Parra","year":"2012","unstructured":"Gonzalez-Parra E, Rojas-Rivera J, Tu\u00f1\u00f3n J, Praga M, Ortiz A, Egido J (2012) Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant 27(Suppl):17\u201321","journal-title":"Nephrol Dial Transplant"},{"key":"706_CR48","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G, Cholesterol And Recurrent Events Trial Investigators (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627\u20132633","journal-title":"Circulation"},{"key":"706_CR49","doi-asserted-by":"crossref","first-page":"e36883","DOI":"10.1371\/journal.pone.0036883","volume":"7","author":"AL Cancela","year":"2012","unstructured":"Cancela AL, Santos RD, Titan SM, Goldenstein PT, Rochitte CE, Lemos PA, dos Reis LM, Graciolli FG, Jorgetti V, Moys\u00e9s RM (2012) Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS One 7:e36883","journal-title":"PLoS One"},{"key":"706_CR50","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","volume":"5","author":"P Evenepoel","year":"2010","unstructured":"Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, Vanderschueren D, Vanrenterghem Y (2010) Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 5:1268\u20131276","journal-title":"Clin J Am Soc Nephrol"},{"key":"706_CR51","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.2010101073","volume":"22","author":"JA Moreno","year":"2011","unstructured":"Moreno JA, Izquierdo MC, Sanchez-Ni\u00f1o MD, Su\u00e1rez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB (2011) The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB. J Am Soc Nephrol 22:1315\u20131325","journal-title":"J Am Soc Nephrol"},{"key":"706_CR52","doi-asserted-by":"crossref","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","volume":"9","author":"H Olauson","year":"2013","unstructured":"Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R, Mohammadi M, Andersson G, Lanske B, Larsson TE (2013) Parathyroid-specific deletion of klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. PLoS Genet 9:e1003975","journal-title":"PLoS Genet"},{"key":"706_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/07435800.2010.496761","volume":"36","author":"AD Polymeris","year":"2011","unstructured":"Polymeris AD, Doumouchtsis KK, Giagourta I, Karga H (2011) Effect of an oral glucose load on PTH, 250HD3, calcium, and phosphorus homeostasis in postmenopausal women. Endocr Res 36:45\u201352","journal-title":"Endocr Res"},{"key":"706_CR54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"Bover J, Ure\u00f1a P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ (2014) Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol 34:626\u2013640","journal-title":"Semin Nephrol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0706-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0706-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T18:30:10Z","timestamp":1567103410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-015-0706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,23]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1007\/s00774-015-0706-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,23]]}}}